Literature DB >> 15024172

Mutagenesis of herpesvirus BACs by allele replacement.

Eva-Maria Borst1, György Pósfai, Frank Pogoda, Martin Messerle.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15024172     DOI： 10.1385/1-59259-753-X:269

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  10 in total

1.  CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.

Authors:  Christian O Simon; Rafaela Holtappels; Hanna-Mari Tervo; Verena Böhm; Torsten Däubner; Silke A Oehrlein-Karpi; Birgit Kühnapfel; Angélique Renzaho; Dennis Strand; Jürgen Podlech; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

2.  Identification of an atypical CD8 T cell epitope encoded by murine cytomegalovirus ORF-M54 gaining dominance after deletion of the immunodominant antiviral CD8 T cell specificities.

Authors:  Rafaela Holtappels; Niels A W Lemmermann; Doris Thomas; Angélique Renzaho; Matthias J Reddehase
Journal:  Med Microbiol Immunol       Date:  2015-03-25       Impact factor: 3.402

3.  A role for the internal repeat of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen in the persistence of an episomal viral genome.

Authors:  Khaled R Alkharsah; Thomas F Schulz
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

4.  Immune evasion proteins of murine cytomegalovirus preferentially affect cell surface display of recently generated peptide presentation complexes.

Authors:  Niels A W Lemmermann; Kerstin Gergely; Verena Böhm; Petra Deegen; Torsten Däubner; Matthias J Reddehase
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

5.  Transactivation of cellular genes involved in nucleotide metabolism by the regulatory IE1 protein of murine cytomegalovirus is not critical for viral replicative fitness in quiescent cells and host tissues.

Authors:  Vanessa Wilhelmi; Christian O Simon; Jürgen Podlech; Verena Böhm; Torsten Däubner; Simone Emde; Dennis Strand; Angélique Renzaho; Niels A W Lemmermann; Christof K Seckert; Matthias J Reddehase; Natascha K A Grzimek
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

6.  Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.

Authors:  Rafaela Holtappels; Christian O Simon; Michael W Munks; Doris Thomas; Petra Deegen; Birgit Kühnapfel; Torsten Däubner; Simone F Emde; Jürgen Podlech; Natascha K A Grzimek; Silke A Oehrlein-Karpi; Ann B Hill; Matthias J Reddehase
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

Review 7.  Reverse genetics modification of cytomegalovirus antigenicity and immunogenicity by CD8 T-cell epitope deletion and insertion.

Authors:  Niels A W Lemmermann; Kai A Kropp; Christof K Seckert; Natascha K A Grzimek; Matthias J Reddehase
Journal:  J Biomed Biotechnol       Date:  2010-12-26

8.  The p36 isoform of murine cytomegalovirus m152 protein suffices for mediating innate and adaptive immune evasion.

Authors:  Annette Fink; Angeliqué Renzaho; Matthias J Reddehase; Niels A W Lemmermann
Journal:  Viruses       Date:  2013-12-16       Impact factor: 5.048

9.  Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation.

Authors:  Emin Gezinir; Jürgen Podlech; Kerstin M Gergely; Sara Becker; Matthias J Reddehase; Niels A W Lemmermann
Journal:  Front Cell Infect Microbiol       Date:  2020-06-09       Impact factor: 5.293

10.  A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins.

Authors:  Jan Hellert; Magdalena Weidner-Glunde; Joern Krausze; Ulrike Richter; Heiko Adler; Roman Fedorov; Marcel Pietrek; Jessica Rückert; Christiane Ritter; Thomas F Schulz; Thorsten Lührs
Journal:  PLoS Pathog       Date:  2013-10-17       Impact factor: 6.823
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.